Lloyd Sems Net Worth & Insider Trades

Lloyd Sems - Director, Cyclacel Pharmaceuticals, Inc

As of June 16, 2022

What is Lloyd Sems's Net Worth?

The current estimated net worth of Cyclacel Pharmaceuticals, Inc's Director, Lloyd Sems, is estimated to be about $21K . Lloyd Sems owns about 33,333 units of Cyclacel Pharmaceuticals, Inc common stock. In the last 10 years at Cyclacel Pharmaceuticals, Inc, Lloyd Sems has sold an estimated value of $0 worth.

What is Lloyd Sems's Past Insider Trading?

Lloyd Sems's largest purchase order was 33,333 units , worth over $100K on May 22, 2013. In total, Lloyd Sems has made about 12 transactions over 10 years of their time at Cyclacel Pharmaceuticals, Inc. Lloyd Sems usually trades in May, with the busiest year in 2013.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Lloyd Sems

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Lloyd Sems's' Mailing Address?

  • Mailing address is C/o Sems Capital 7 Dey Street, Suite 1101 New York NY 10017 NY

What are Cyclacel Pharmaceuticals, Inc's Past Insider Trades?

Cyclacel Pharmaceuticals, Inc's most recent insider trade came on December 2, 2021 by Sam L Barker who sold 12 units worth $42.86 . In the last 15 years, insiders at Cyclacel Pharmaceuticals, Inc have sold an estimated value of $7.67M and bought an estimated value of $14.98M worth of shares. Insider trading is most common in May, with the busiest year in 2008. The most active traders at the company are Spiro Rombotis, President and CEO,  Morgan Stanley,  and David C. U'Prichard, Director .

Cyclacel Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...